statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This indicator may be signaling that RAPT's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

RAPT Therapeutics (RAPT, $8.45) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

This is a signal that RAPT's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

RAPT Therapeutics (RAPT, $8.45) Stochastic Oscillator left the overbought zone on April 01, 2024

RAPT Therapeutics (NASDAQ:RAPT - Free Report) had its price objective reduced by JPMorgan Chase  Co. from $15.00 to $13.00 in a research note published on Wednesday, Benzinga reports. JPMorgan...

JPMorgan Chase & Co. Trims RAPT Therapeutics (NASDAQ:RAPT) Target Price to $13.00

This is a signal that RAPT's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

RAPT Therapeutics (RAPT, $8.6) RSI Indicator left the oversold zone on March 13, 2024

RAPT Therapeutics, Inc. (NASDAQ:RAPT  Get Free Report) has earned an average recommendation of Moderate Buy from the fourteen research firms that are covering the company...

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives $28.67 Average PT from Brokerages

RAPT Therapeutics (RAPT, $8.1) entered Downtrend as Momentum indicator drops below 0 level on Mar 11, 2024

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against RAPT Therapeutics, Inc...

RAPT ALERT: Bragar Eagel & Squire, P.C. is Investigating RAPT Therapeutics, Inc. on Behalf of RAPT Stockholders and Encourages Investors to Contact the Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on RAPT Therapeutics (RAPT Research Report), Eli Lilly  Co...

Analysts Conflicted on These Healthcare Names: RAPT Therapeutics (RAPT), Eli Lilly & Co (LLY) and Sight Sciences (SGHT)

This indicator may be signaling RAPT's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

RAPT Therapeutics (RAPT, $9.28) entered Uptrend as Momentum indicator ascends above 0 level on Mar 07, 2024

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Volume	5.00
52-Wk High	$27.35
52-Wk Low	$6.86

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.81	--	--	N/A
Q4'23	-$0.86	-$0.80	6.90%	BEAT
Q3'23	-$0.75	-$0.82	-8.86%	MISSED
Q2'23	-$0.78	-$0.66	15.49%	BEAT
Q1'23	-$0.67	-$0.76	-13.09%	MISSED

RAPT RAPT Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals